Skip to content

Clinical trials

Recruiting Phase 1/2 Breast Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 1/2 Status: Recruiting Clear all

94 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20171
20182
20191
20202
20217
20229
202317
202415
202524
202615

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting94

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Essen Biotech3
National University Hospital, Singapore3
Shandong Suncadia Medicine Co., Ltd.3
AstraZeneca2
Beijing Biotech2
DualityBio Inc.2
Forward Pharmaceuticals Co., Ltd.2
Fudan University2
Jiangsu HengRui Medicine Co., Ltd.2
Novartis Pharmaceuticals2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms94
Ovarian Neoplasms24
Prostatic Neoplasms16
Endometrial Neoplasms15
Neoplasm Metastasis14
Triple Negative Breast Neoplasms14
Carcinoma, Non-Small-Cell Lung13
Colorectal Neoplasms12
Pancreatic Neoplasms12
Stomach Neoplasms11

Trials

Showing 1 to 25 of 94. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.